Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung disease that makes it difficult to breathe. It is caused by long-term exposure to irritants, such as cigarette smoke. The two most common conditions that contribute to COPD are emphysema and chronic bronchitis. Emphysema is a condition in which the alveoli, or air sacs, in the lungs are destroyed. Chronic bronchitis is inflammation of the lining of the bronchial tubes. COPD is a progressive disease, but it is treatable. With proper management, most people with COPD can achieve good symptom control and quality of life.
Patients are the experts in their condition and advocacy groups provide a platform for patient voices. Working directly with these communities is the key to pushing research forward in an inclusive way.
We’ve committed to having 500,000 conversations in the next three years, to equip ourselves and our Pharma partners with the insights needed to increase predictability.
The ever-growing investment in advocacy doesn’t appear to be slowing down, and research is certainly seeing the benefits. Which at the end of the day, means better patient care and more options for patients.
We’re ready to keep forming links between our Advocacy friends and Pharma partners, so these fruitful relationships continue to evolve beyond the study-to-study view.
Add your voice to the research conversation
Share My Story